Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania

BACKGROUND: Primaquine is a gametocytocidal drug recommended by the World Health Organization (WHO) in a single-low dose combined with artemisinin-based combination therapy (ACT) for the treatment and prevention of Plasmodium falciparum malaria transmission. Safety monitoring concerns and the lack o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosha, Dominic, Kakolwa, Mwaka A., Mahende, Muhidin K., Masanja, Honorati, Abdulla, Salim, Drakeley, Chris, Gosling, Roland, Wamoyi, Joyce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501629/
https://www.ncbi.nlm.nih.gov/pubmed/34627236
http://dx.doi.org/10.1186/s12936-021-03921-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501629/
https://www.ncbi.nlm.nih.gov/pubmed/34627236
http://dx.doi.org/10.1186/s12936-021-03921-w

Ejemplares similares